3Yaney CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.J Am Coll Cardiol,2013,62(16):e 147-e239.
4Fatkin D.Guidelines for the diagnosis and management of familial dilated cardiomyopathy.Heart Lung Cire,2011,20(11):691-693.
5Petretta M,Pirozzi F,Sasso L,et al.Review and metaanalysis of the frequency of familial dilated cardiomyopathy.Am J Cardiol,2011,108(8):1171-1176.
6Hershberger RE,Siegfried JD.Update 2011:clinical and genetic issues in familied dilated cardiomyopathy.Am J Cardiol,2011,57(16):1641-1649.
7van Spaendonck-Zwarts K Y,van Rijsingen I A,van den Berg M P,et al.Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy:overview of 10 years" experience.European journal of heart failure 2013 Jun;15(6):628-636.
8Lu QW,Morimoto S,Harada K,et al.Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca^2+ desensitization.J Mol Cell Cardiol,2003,35(12):1421-1427.
9Memo M,Leung MC,Ward DG,et al.Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca^2+ sensitivity.Cardiovasc Res,2013,99(1):65-73.
10Pugh TJ,Kelly MA,Gowrlsankar S,et al.The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.Genet Med,2014,Epub ahead of print.
